A total of 610 COVID-
19 patients were enrolled after admission from various centers in the Zheijiang
province (Figure 1). A population-based cohort from the Zhejiang province consisting
of 48,667 adults with health records was used as controls. The descriptive
characteristics, comorbidities and use of medication available in both cases and
controls were compared